info icon

LeFortI or BSSRO operation

OPER_LEFORT1_BSSRO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: NOMESCO ^EEC05|^EDC10
  • Operations: NOMESCO codes ^EEC05|^EDC10

2 out of 7 registries used, show all original rules.

1648

4. Check minimum number of events

None

1648

5. Include endpoints

None

1648

6. Filter based on genotype QC (FinnGen only)

1648

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1648 1181 467
Unadjusted period prevalence (%) 0.35 0.40 0.21
Median age at first event (years) 37.86 36.94 40.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1467
Matched controls
14671
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.13
ICD-10 Finland
Retrognaty, mandibular
486.1
323.0
961
57
SAA04
NOMESCO Finland
Special inverstigation of mouth
29.1
323.0
614
354
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
170.6
323.0
780
97
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
25.2
323.0
489
285
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
182.7
323.0
725
78
EEC05
NOMESCO Finland
Le Fort I osteotomy
+∞
323.0
563
*
K07.23
ICD-10 Finland
Deep bite
55.8
323.0
441
112
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
201.4
323.0
844
98
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
123.1
323.0
476
57
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
67.1
323.0
693
193
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
+∞
323.0
1201
*
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
114.7
323.0
646
100
SBB10
NOMESCO Finland
Teeth copy
54.8
323.0
968
501
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
79.9
323.0
419
73
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
154.8
323.0
508
50
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
76.2
323.0
765
207
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
150.4
323.0
694
87
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
207.4
323.0
669
59
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
90.4
323.0
529
91
EB1MA
NOMESCO Finland
Cephalometry with X-ray
74.3
323.0
549
117
SJC00
NOMESCO Finland
Bracket with fixed attachment
205.9
279.5
283
17
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
91.7
279.2
306
42
K07.24
ICD-10 Finland
Open bite
61.8
278.4
324
67
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
53.3
277.7
332
80
SXC05
NOMESCO Finland
Other oral or dental procedure
16.2
276.7
480
427
K07.14
ICD-10 Finland
Retrognaty, maxillary
320.0
266.4
263
10
SJB60
NOMESCO Finland
External device grinding and adaptation
51.5
250.1
301
73
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
44.3
247.3
307
87
K07.10
ICD-10 Finland
Asymmetry of jaw
209.7
241.5
245
14
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
8.5
236.6
616
1155
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
255.3
235.5
236
11
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
56.0
221.9
263
57
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
172.3
213.2
220
15
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
37.7
211.3
272
88
SAA03
NOMESCO Finland
Extended examination of mouth
5.3
189.7
1024
4457
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
12.8
187.8
356
357
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
199.3
186.8
191
11
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
316.8
168.6
168
6
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
192.0
165.6
170
10
K07.60
ICD-10 Finland
Snapping jaw
9.7
161.0
357
473
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
14.7
160.2
282
234
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
7.8
156.9
403
676
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
24.7
154.1
222
105
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
40.5
153.4
194
55
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
160.8
151.7
158
11
EBB10
NOMESCO Finland
Insertion of dental implant
34.8
150.5
197
65
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
8.9
148.1
343
484
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
53.6
146.4
175
37
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
193.2
136.1
140
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
136.0
795
3291
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
52.4
129.2
155
33
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
39.2
111.7
142
40
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
232.9
106.1
108
5
EBB15
NOMESCO Finland
Insertion of dental implant abutment
46.6
97.9
120
28
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
27.8
95.4
132
52
K07.22
ICD-10 Finland
Anomalies of dental arch relationship
52.6
93.5
112
23
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
203.0
92.5
95
5
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
40.3
88.8
112
30
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.0
85.7
830
4456
EBA10
NOMESCO Finland
Surgical removal of tooth
3.9
85.0
425
1400
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
419.8
80.7
80
*
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
34.5
78.9
103
32
EDC30
NOMESCO Finland
Genioplasty
403.0
77.6
77
*
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
99.0
76.8
84
9
K00.00
ICD-10 Finland
Hypodontia
25.3
76.2
108
46
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.4
74.2
243
518
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
16.8
72.5
118
76
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
28.0
70.5
97
37
SJA02
NOMESCO Finland
Plan for orthodontic care
244.8
68.9
70
*
SXC03
NOMESCO Finland
Other oral or dental procedure
21.1
64.9
97
49
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
15.8
63.7
106
72
K01.0
ICD-10 Finland
Embedded teeth
8.4
55.7
128
166
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
13.2
55.3
99
80
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
55.2
284
920
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
46.0
54.0
66
15
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.5
53.9
108
110
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
14.2
52.1
90
67
ZXA10
NOMESCO Finland
Bilateral
3.1
50.5
325
1233
J01CE02
ATC
phenoxymethylpenicillin; oral
2.6
49.6
1185
9092
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
109.9
49.1
53
5
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
24.9
48.8
69
29
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.6
48.8
131
214
SAA02
NOMESCO Finland
Basic examination of mouth
2.5
48.1
1139
8599
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
38.4
46.6
59
16
EB1WA
NOMESCO Finland
NA
26.7
46.3
64
25
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
7.0
43.5
112
172
K07.27
ICD-10 Finland
Anomalies of dental arch relationship
33.6
42.2
55
17
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
151.1
42.0
44
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.3
40.9
164
421
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
210.7
40.0
41
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.9
39.2
272
1068
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
48.5
39.0
47
10
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
13.1
38.8
69
55
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
9.7
38.6
80
87
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
38.2
123
251
SPB10
NOMESCO Finland
Production of temporary crone to tooth
20.4
38.1
57
29
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
9.0
37.4
81
95
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.4
36.0
138
338
SDA02
NOMESCO Finland
Parodonthologic therapy
2.1
35.8
590
3583
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
35.5
443
2379
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
35.4
165
483
EFB50
NOMESCO Finland
Orthodontic procedure connected with ortognathic surgery
355.4
35.1
35
*
EEC02
NOMESCO Finland
Rapid expansion of maxilla
94.9
33.9
37
*
K07.0
ICD-10 Finland
Major anomalies of jaw size
122.9
33.8
36
*
K07.9
ICD-10 Finland
Dentofacial anomaly, unspecified
173.9
32.8
34
*
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
63.2
32.2
37
6
OIKK
NOMESCO Finland
NA
7.6
31.8
76
105
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
31.4
527
3177
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
71.5
31.0
35
5
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
17.7
30.7
48
28
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
11.3
30.7
58
53
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.5
30.6
112
262
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
21.6
30.1
44
21
K07.4
ICD-10 Finland
Malocclusion, unspecified
7.6
29.7
71
98
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
28.9
1141
9306
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.0
28.7
446
2588
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
19.6
27.9
42
22
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
142.6
26.7
28
*
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
25.3
26.7
37
15
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
12.4
26.6
48
40
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
29.8
26.4
35
12
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
4.5
25.2
92
215
SPAT1324
SPAT
Screening procedure
2.0
24.3
398
2331
K07.00
ICD-10 Finland
Macrognatia (hyperplasia) of the upper jaw
127.1
23.6
25
*
EEC00
NOMESCO Finland
Segmental osteotomy of maxilla
+∞
23.0
22
*
EDW99
NOMESCO Finland
Other operation on mandible
66.1
22.9
26
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
22.9
503
3259
ZXX07
NOMESCO Finland
Extent of procedure, 7 units
116.8
21.6
23
*
K07.61
ICD-10 Finland
Cracking jaw joint
5.0
20.0
65
135
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
7.0
19.8
49
72
N02BE01
ATC
paracetamol; systemic, rectal
1.9
19.6
1210
10510
EBA00
NOMESCO Finland
Extraction of tooth
1.7
19.1
496
3343
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
13.0
18.9
33
26
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.3
18.8
194
925
DLW00
NOMESCO Finland
Correction of cleft nose
+∞
18.8
18
*
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.8
18.6
421
2714
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
4.1
18.4
73
186
SPC08
NOMESCO Finland
Implant crown
22.0
18.2
26
12
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
18.1
575
4094
EB1BD
NOMESCO Finland
Extensive cone beam CT of teeth and jaws (two quarters)
27.1
17.8
24
9
K07.09
ICD-10 Finland
Anomaly in the size of the jaws UNS
96.2
17.6
19
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
17.5
482
3286
R06.5
ICD-10 Finland
Mouth breathing
2.5
17.5
147
631
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
24.4
17.3
24
10
J01FF01
ATC
clindamycin; systemic
1.8
17.3
387
2479
EEC45
NOMESCO Finland
Reconstruction of maxilla using bone graft
35.5
16.7
21
6
Q35.1
ICD-10 Finland
Cleft hard palate
40.6
16.3
20
5
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
8.5
16.3
35
42
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
16.2
1363
12554
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
13.0
16.2
28
22
ZZH22
NOMESCO Finland
Graft of patients own bone, block
14.7
15.9
26
18
4361
FHL
Lip plastic or reconstruction due to cleft lip
60.7
15.8
18
*
EAB30
NOMESCO Finland
Correction of cleft lip
+∞
15.6
15
*
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
86.0
15.6
17
*
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
13.9
15.5
26
19
SPAT1263
SPAT
Sampling
1.6
15.4
583
4294
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.0
14.9
85
290
Z47.0
ICD-10 Finland
Follow-up care involving removal of fracture plate and other internal fixation device
11.4
14.8
27
24
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
25.3
14.7
20
8
K07.2
ICD-10 Finland
Anomalies of dental arch relationship
+∞
14.6
14
*
K06.00
ICD-10 Finland
Local gingivore traction
5.3
14.6
44
85
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
80.9
14.6
16
*
SXB10
NOMESCO Finland
Removal of attachments and rails from moth
14.3
14.6
24
17
EGC10
NOMESCO Finland
Arthroplasty of mandibular joint without graft
151.5
14.5
15
*
SPC25
NOMESCO Finland
Other demanding attachment of crone of tooth
17.2
14.3
22
13
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.4
13.9
50
117
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
17.7
13.8
21
12
ECB17
NOMESCO Finland
Operation for cleft gingiva
53.9
13.8
16
*
EBA40
NOMESCO Finland
Excision of apex of root of tooth
5.9
13.8
38
66
TEG00
NOMESCO Finland
Punction of mandibular joint
20.3
13.8
20
10
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
10.6
13.7
26
25
EMAK
NOMESCO Finland
NA
2.9
13.7
84
301
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
13.6
493
3562
XX2XX
NOMESCO Finland
NA
+∞
13.6
13
*
WX720
NOMESCO Finland
Own respiration
3.2
13.5
70
224
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.0
13.2
77
267
4362
FHL
Nozzle reconstruction
40.5
13.2
16
*
SPC09
NOMESCO Finland
Implant crown, demanding
40.5
13.2
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
13.0
129
601
N03AX16
ATC
pregabalin; oral
1.7
12.9
302
1939
EB1TW
NOMESCO Finland
3D modelling of dentition
70.5
12.6
14
*
EGC30
NOMESCO Finland
Prosthetic replacement of mandibular joint
70.5
12.6
14
*
SJD60
NOMESCO Finland
NA
+∞
12.5
12
*
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
24.5
12.5
17
7
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
131.1
12.5
13
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.2
627
4877
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.3
12.1
44
105
ECB10
NOMESCO Finland
Reconstruction of gingiva
21.5
12.0
17
8
WX704
NOMESCO Finland
Intubation
2.3
11.9
113
517
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
11.8
521
3911
G50.1
ICD-10 Finland
Atypical facial pain
4.6
11.8
40
89
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
65.5
11.6
13
*
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
4.6
11.6
39
86
K07.05
ICD-10 Finland
Micrognatia (hypoplasia) of both jaws
120.9
11.4
12
*
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
120.9
11.4
12
*
ECB05
NOMESCO Finland
Mucogingival repair
11.9
11.3
20
17
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
15.2
11.3
18
12
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
9.0
11.3
23
26
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
17.2
11.2
17
10
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
17.2
11.2
17
10
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.9
11.1
66
233
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.4
11.1
39
90
ECB20
NOMESCO Finland
Oral alveoplasty
9.3
11.0
22
24
SPC50
NOMESCO Finland
Pivot column
43.7
10.9
13
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
10.7
99
449
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
10.5
433
3180
P01AB01
ATC
metronidazole; oral, rectal
1.5
10.4
553
4289
EEC42
NOMESCO Finland
Reconstruction of maxilla using implant
+∞
10.4
10
*
ECA50
NOMESCO Finland
Parodontal operation
7.2
10.3
24
34
HAMTE
NOMESCO Finland
NA
6.7
10.2
25
38
G47.3
ICD-10 Finland
Sleep apnoea
1.6
10.1
261
1712
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
40.3
10.0
12
*
WX402
NOMESCO Finland
General anaesthesia
1.7
10.0
231
1471
EB1S1
NOMESCO Finland
Photography of teeth
16.8
9.9
15
9
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.6
486
3719
K07.68
ICD-10 Finland
Other disorders of the jaw joint
6.4
9.6
24
38
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
9.2
9.5
19
21
DLD20
NOMESCO Finland
Rhinoplasty
15.1
9.5
15
10
A02BC03
ATC
lansoprazole; oral
1.5
9.4
330
2330
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.6
9.4
41
117
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
8.1
9.3
20
25
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
5.5
9.2
26
48
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
18.7
8.9
13
7
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
8.9
335
2402
Z01.9
ICD-10 Finland
Special examination, unspecified
2.5
8.9
70
292
J34.2
ICD-10 Finland
Deviated nasal septum
2.3
8.9
77
340
Z01.2
ICD-10 Finland
Dental examination
1.4
8.8
598
4818
F45.8
ICD-10 Finland
Other somatoform disorders
1.8
8.7
141
802
EEW99
NOMESCO Finland
Other operation on maxilla
50.3
8.7
10
*
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
6.6
8.7
21
32
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
8.6
350
2544
SCB02
NOMESCO Finland
Training for mouth care at home
16.4
8.6
13
8
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.0
8.5
22
37
AA6AD
NOMESCO Finland
Cranial bones CT examination
90.6
8.4
9
*
EDC99
NOMESCO Finland
Other reconstructive operations on mandible
90.6
8.4
9
*
K07.33
ICD-10 Finland
Crowding of tooth or teeth
12.8
8.4
14
11
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
7.9
8.4
18
23
4368
FHL
Closing the fistula of the mouth
+∞
8.3
8
*
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
+∞
8.3
8
*
EG1DM
NOMESCO Finland
Mandipular joint very extensive MRI examination with 3 Tesla magnet
+∞
8.3
8
*
SJC20
NOMESCO Finland
Extraoral ofthodontisk pulling device arrangement and urser information
33.5
8.1
10
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
4.5
8.1
27
61
M79.1
ICD-10 Finland
Myalgia
1.7
8.0
180
1132
A02BC05
ATC
esomeprazole; systemic
1.4
8.0
482
3786
ZXB10
NOMESCO Finland
Medial
7.8
7.9
17
22
K07
ICD-10 Finland
Dentofacial anomalies [including malocclusion]
6.1
7.9
20
33
EBW99
NOMESCO Finland
Other operation on tooth
45.2
7.7
9
*
UDC00
NOMESCO Finland
Ear microscopy
2.0
7.7
90
455
EG1DG
NOMESCO Finland
Very extensive MRI examination of mandipular joint with high intensity magnet
18.5
7.6
11
6
ZSZ10
NOMESCO Finland
Secondary repair operation
18.5
7.6
11
6
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
8.1
7.6
16
20
SPC30
NOMESCO Finland
Tooth bridge attacment with resins
5.8
7.5
20
35
K07.08
ICD-10 Finland
Other specified anomaly in the size of the cores
80.5
7.4
8
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.5
7.4
18
28
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
13.4
7.4
12
9
SPA05
NOMESCO Finland
Guiding rail
13.4
7.4
12
9
XX7LW
NOMESCO Finland
NA
13.4
7.4
12
9
K05.30
ICD-10 Finland
Periodontitis complex
1.7
7.3
141
846
SFB30
NOMESCO Finland
Filling of tree or more surfaces of tooth reproduced outside mouth
8.4
7.3
15
18
SPF50
NOMESCO Finland
Removal and reattachment with cement of tooth bridnge
10.9
7.3
13
12
EHC40
NOMESCO Finland
Correction of submucous cleft palate
+∞
7.3
7
*
M01AE02
ATC
naproxen; oral, rectal
1.3
7.3
782
6725
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.2
265
1879
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
7.2
65
291
WX110
NOMESCO Finland
Local anesthesy
1.4
7.2
983
8775
SCB01
NOMESCO Finland
Simple training for mouth care at home
4.7
7.0
22
47
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
4.0
7.0
26
66
SPAT1301
SPAT
No procedures
1.4
6.9
344
2595
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.9
755
6490
J01DB01
ATC
cefalexin; oral
1.4
6.9
1142
10482
AA3AD
NOMESCO Finland
CT of face
7.6
6.9
15
20
R01AD09
ATC
mometasone; nasal
1.3
6.9
643
5395
K05.22
ICD-10 Finland
Acute pericoronitis
0.3
6.8
15
476
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.3
6.8
19
36
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
6.8
121
714
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.5
6.7
51
212
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
2.3
6.7
59
264
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
3.2
6.6
32
101
WX199
NOMESCO Finland
Other local analgesia
3.5
6.6
29
85
XF400
NOMESCO Finland
ECG with 12 standard connections
0.5
6.6
46
922
AA1AA
NOMESCO Finland
Head X-ray examination
7.8
6.6
14
18
K01.16
ICD-10 Finland
Retained molar with obstruction in the upper jaw
3.3
6.5
30
92
SPAT1153
SPAT
Removal of sutures
1.4
6.4
325
2455
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
70.2
6.4
7
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.4
455
3647
SFA00
NOMESCO Finland
Small filling
1.6
6.4
177
1177
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.9
6.4
92
505
XX1VW
NOMESCO Finland
Written report from radiologist
6.6
6.3
15
23
M03BX02
ATC
tizanidine; oral
1.3
6.3
872
7713
K03.39
ICD-10 Finland
Pathological resorption of teeth UNS
18.1
6.3
9
5
S02.60
ICD-10 Finland
Fracture of mandible, closed
18.1
6.3
9
5
EDC05
NOMESCO Finland
Segmental osteotomy of mandible
+∞
6.3
6
*
EFU00
NOMESCO Finland
Removal of implant or external fixation device from jaws
+∞
6.3
6
*
TEB00
NOMESCO Finland
Restoration of crown of tooth
+∞
6.3
6
*
EFB60
NOMESCO Finland
Osteoplasty of jaws or facial bones with use of osseous graft or foreign material
+∞
6.3
6
*
EG1AD
NOMESCO Finland
CT of mandipular joint
+∞
6.3
6
*
KMAK
NOMESCO Finland
NA
1.3
6.2
772
6715
J02AC01
ATC
fluconazole; systemic
1.3
6.2
590
4938
EEC99
NOMESCO Finland
Other reconstructive operations on maxilla
26.8
6.2
8
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.4
6.2
408
3223
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.3
6.2
53
233
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
12.6
6.1
10
8
T84.62
ICD-10 Finland
Osteitis associated with dental implants
8.6
6.1
12
14
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
2.3
6.0
52
231

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
698
5173
1.61
18.81
3.2
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
793
6208
1.53
15.91
3.9
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
518
3873
1.49
12.01
2.6
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
804
6579
1.43
11.46
3.1
3.0
estimate
0.0
0.0
0.50
172
1248
(3009261) Glucose [Presence] in Urine by Test strip
806
6651
1.41
10.68
3.2
3.0
estimate
0.0
0.0
1.06
170
1238
(3021601) Nitrite [Presence] in Urine by Test strip
797
6600
1.40
10.16
4.3
4.2
estimate
0.0
0.0
0.41
176
1290
(3029937) Albumin [Presence] in Urine by Test strip
459
3445
1.46
10.13
3.5
3.3
estimate
0.0
0.0
1.28
175
1270
(3013707) Erythrocyte sedimentation rate by Westergren method
1101
9707
1.40
9.28
4.0
3.8
mm/h
8.2
9.5
5.20
1047
9128
(1761482) Bacteria [#/volume] in Urine by Culture
51
213
2.44
7.96
3.7
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
304
2212
1.46
7.64
1.5
1.6
pmol/l
36900821.2
41037922.9
0.05
271
1947
(3030981) Hyaline casts [#/volume] in Urine by Automated count
96
524
1.88
7.58
1.9
2.5
e6/l
0.1
0.2
0.46
91
499
(40760892) CBC W Ordered Manual Differential panel - Blood
433
3408
1.37
6.86
4.1
4.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
365
2821
1.38
6.43
3.5
3.3
kg/l
1.0
1.0
0.04
50
390
(3047181) Lactate [Moles/volume] in Blood
63
316
2.03
6.39
2.2
9.2
mmol/l
1.3
1.2
0.25
57
271
(40761511) CBC panel - Blood by Automated count
1540
14798
1.62
5.58
10.3
9.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
66
355
1.89
5.52
2.8
8.2
%
1.5
1.7
1.48
61
328
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1358
12772
1.36
5.26
4.7
4.7
mu/l
1.7
2.0
0.99
1292
12105
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1189
10994
1.29
5.08
4.3
4.1
pmol/l
14.3
14.4
0.50
1123
10307
(3025159) Blasts/100 leukocytes in Blood
136
930
1.50
4.65
3.5
4.2
%
0.0
0.5
0.65
16
201
(3033658) Prothrombin time (PT) actual/Normal
238
3069
0.74
4.49
3.1
3.5
%
97.7
97.0
0.17
229
2980
(3017181) Myelocytes/100 leukocytes in Blood
147
1029
1.47
4.48
3.5
4.1
%
1.0
1.0
0.01
28
261
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
74
1189
0.60
4.37
2.5
2.4
u/l
33.0
79.2
0.61
63
1024
(3002179) Metamyelocytes/100 leukocytes in Blood
137
954
1.48
4.30
3.4
3.9
%
1.1
0.6
0.52
16
193
(3023103) Potassium [Moles/volume] in Serum or Plasma
1423
13576
1.35
4.25
9.0
10.9
mmol/l
3.9
3.9
0.01
1397
13218
(3021440) Promyelocytes/100 leukocytes in Blood
140
982
1.47
4.24
3.5
4.2
%
0.2
0.2
0.09
24
238
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
119
1700
0.68
4.10
2.2
2.5
e6/l
2.5
3.3
0.64
71
864
(3007853) Bacteria identified in Skin by Aerobe culture
195
1467
1.37
3.99
1.8
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
150
1081
1.43
3.95
1.3
1.3
u/ml
132.7
217.9
1.58
145
1009
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
486
0.42
3.93
4.1
10.2
mmol/l
23.1
24.3
1.12
16
465
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
112
769
1.49
3.79
1.4
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
451
3823
1.25
3.79
2.4
2.5
u/l
53.6
55.3
0.65
426
3583
(3019550) Sodium [Moles/volume] in Serum or Plasma
1414
13524
1.32
3.78
8.9
10.8
mmol/l
139.8
139.7
2.36
1390
13191
(1761868) Lipid panel - Serum or Plasma
666
5887
1.22
3.76
2.6
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
124
871
1.46
3.75
3.5
3.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
30
141
2.15
3.72
2.6
1.9
nmol/l
22.5
20.1
0.67
30
133
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
279
2249
1.29
3.55
1.5
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
110
767
1.47
3.47
1.3
1.3
miu/ml
218.5
218.8
0.00
55
384
(3008037) Lactate [Moles/volume] in Venous blood
33
166
2.01
3.45
2.4
2.7
mmol/l
1.5
1.4
0.34
33
160
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1445
13898
1.32
3.43
9.8
10.7
mg/l
17.3
20.1
2.85
1129
10659
(3037467) Urinalysis macro (dipstick) panel - Urine
984
9083
1.21
3.42
3.8
3.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
1319
0.67
3.40
2.7
3.6
%
30.2
31.4
0.60
72
996
(3008152) Bicarbonate [Moles/volume] in Arterial blood
81
537
1.53
3.27
3.6
9.3
mmol/l
24.1
24.6
0.53
75
494
(3007461) Platelets [#/volume] in Blood
1610
15809
1.80
3.27
15.2
15.7
e9/l
259.6
261.6
0.72
1598
15496
(4035726)
65
1000
0.64
3.24
1.3
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
1611
15827
1.80
3.18
15.1
15.6
pg
30.2
30.1
0.96
1605
15679
(3024731) MCV [Entitic volume]
1611
15827
1.80
3.18
15.1
15.6
fl
90.2
90.2
0.10
1605
15681
(3026361) Erythrocytes [#/volume] in Blood
1611
15829
1.79
3.15
15.2
15.7
e12/l
4.6
4.6
0.64
1599
15499
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1039
9677
1.20
3.14
5.8
6.9
u/l
70.7
74.4
4.39
994
9178
(3010813) Leukocytes [#/volume] in Blood
1611
15832
1.78
3.10
15.2
15.7
e9/l
6.4
6.6
2.80
1597
15492
(3000991) Gas panel - Venous blood
47
770
0.60
3.07
4.1
8.6
—
—
—
0
0
(44813793)
25
119
2.12
3.05
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
284
0.35
3.04
2.7
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
125
917
1.39
3.02
2.5
2.2
nmol/l
12.4
12.6
0.07
115
837
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
141
1056
1.37
3.01
2.3
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
454
3934
1.21
3.00
1.9
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
450
3896
1.21
3.00
2.3
2.7
ng/l
29.6
38.1
0.36
219
1988
(3000963) Hemoglobin [Mass/volume] in Blood
1611
15839
1.76
2.99
15.3
15.8
g/l
137.5
136.8
1.55
1605
15689
(3009214) Lutropin [Units/volume] in Serum or Plasma
85
585
1.48
2.91
1.2
1.4
u/l
10.8
10.5
0.06
69
482
(40758558) Short blood count panel - Blood
273
3270
0.80
2.81
4.2
6.6
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
73
0.00
2.78
0.0
2.0
—
145.8
—
0
67
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
84
588
1.45
2.66
1.8
2.8
ng/l
63.1
130.1
4.02
74
509
(3017569) Oxygen content in Arterial blood
10
32
3.14
2.65
2.3
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
505
0.55
2.64
1.5
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
61
2.47
2.62
3.5
2.3
ug/l
0.7
1.0
0.61
15
56
(3002385) Erythrocyte distribution width [Ratio]
1270
12129
1.21
2.60
11.3
12.8
%
13.3
13.5
1.77
1236
11901
(3052851) Hemolysis interference index of Serum or Plasma
16
344
0.46
2.58
2.3
3.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
745
1.39
2.57
1.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
428
3741
1.19
2.54
1.7
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
88
2.17
2.51
1.5
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
928
8651
1.17
2.47
2.8
2.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1331
12789
1.21
2.45
12.4
13.2
g/l
333.7
333.2
1.59
1323
12698
(3015171) Extractable nuclear Ab [Units/volume] in Serum
86
615
1.42
2.45
1.3
1.3
u/ml
0.2
1.3
—
5
51
(3026389) Candida sp identified in Specimen by Organism specific culture
31
174
1.80
2.43
1.5
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
40
2.76
2.37
2.5
3.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
19
91
2.10
2.33
1.5
2.4
mmol/l
3.9
4.0
0.23
19
91
(3035285) Chloride [Moles/volume] in Venous blood
19
91
2.10
2.33
1.5
2.4
mmol/l
105.6
105.4
0.09
19
91
(3001122) Ferritin [Mass/volume] in Serum or Plasma
732
6723
1.16
2.32
2.6
2.8
ug/l
74.6
90.7
3.87
702
6366
(3026008) Bacteria identified in Urine by Culture
370
3217
1.19
2.31
2.4
2.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
117
890
1.34
2.31
1.6
1.6
mu/l
293.7
298.4
0.05
105
798
(3003458) Phosphate [Moles/volume] in Serum or Plasma
98
1303
0.74
2.28
3.7
6.0
mmol/l
1.0
1.0
1.57
88
1233
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
356
3093
1.19
2.24
1.5
1.7
mg/l
0.7
0.9
1.81
253
2280
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
381
3331
1.19
2.23
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
114
869
1.34
2.23
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
56
378
1.50
2.17
1.1
1.1
u/ml
4.2
5.6
0.30
29
193
(3023323) Follitropin [Units/volume] in Serum or Plasma
150
1196
1.28
2.13
1.2
1.3
iu/l
27.0
26.6
0.05
132
1014
(3023430) Cat dander IgE Ab [Units/volume] in Serum
44
284
1.56
2.10
1.1
1.1
u/ml
1.6
5.3
2.51
24
115
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
86
634
1.38
2.10
1.9
1.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
51
341
1.51
2.08
1.4
1.4
u/l
19.8
23.2
0.41
41
291
(3021589) Normoblasts [#/volume] in Blood
644
5897
1.15
2.07
7.8
8.2
e9/l
0.0
0.0
1.21
575
4854
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1351
13054
1.19
2.05
3.4
3.4
mmol/l
1.3
1.3
0.22
1296
12416
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
23
126
1.84
1.98
1.6
1.6
%
35.3
54.2
0.98
12
83
(36304419) Bacteria [Presence] in Urine
267
3098
0.84
1.97
2.3
2.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
56
387
1.46
1.97
2.6
3.3
mmol/l
25.5
25.4
0.14
56
373
(4034850)
61
430
1.43
1.94
5.4
8.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1201
11513
1.16
1.93
3.5
3.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
11
45
2.45
1.93
1.1
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
28
458
0.60
1.92
2.5
3.7
mmol/l
24.3
24.2
0.07
20
415
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
346
3044
1.17
1.87
2.1
2.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
52
361
1.45
1.80
1.0
1.1
u/ml
0.3
1.7
1.59
18
143
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
569
0.66
1.78
1.6
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1412
13737
1.19
1.78
3.9
4.0
mmol/l
3.0
2.9
1.22
1350
13047
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
59
421
1.42
1.78
1.1
1.1
u/ml
0.4
1.5
1.71
26
164
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
61
438
1.41
1.77
1.6
1.6
iu/ml
0.1
0.2
—
9
75
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
311
2725
1.17
1.77
2.1
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1395
13561
1.19
1.75
3.6
3.7
mmol/l
1.5
1.5
1.61
1337
12917
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
192
0.47
1.73
2.2
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
292
2552
1.18
1.72
1.3
1.3
u/ml
8.0
9.6
0.23
153
1082
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
90
692
1.32
1.72
1.7
2.1
ug/l
4.3
7.2
2.23
85
628
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
48
0.00
1.69
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
48
0.00
1.69
0.0
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
48
0.00
1.69
0.0
1.6
—
—
—
0
0
(3013512) EKG study
323
2852
1.16
1.67
2.6
2.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
91
704
1.31
1.67
1.5
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
355
0.59
1.67
2.0
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
743
6944
1.13
1.65
3.1
4.3
mmol/l
6.2
6.4
2.13
676
6383
(4281824)
5
130
0.38
1.62
1.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
14
3.58
1.61
10.2
5.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1397
13604
1.18
1.60
3.8
3.7
mmol/l
4.9
4.8
1.24
1337
13012
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
151
1811
0.82
1.59
2.1
2.4
e6/l
1.3
1.3
0.01
100
974
(3030467) Casts [#/volume] in Urine by Automated count
271
3084
0.85
1.59
2.4
2.6
e6/l
0.2
0.4
1.22
215
2276
(3031040) Bacteria [#/volume] in Urine by Automated count
895
8478
1.12
1.55
3.6
3.6
e6/l
1253.3
851.8
0.20
12
90
(40765089) Chromosome analysis panel - Blood by G-banded
15
78
1.93
1.54
1.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
380
4210
0.87
1.54
5.4
6.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
45
315
1.44
1.53
1.2
1.1
u/ml
5.0
4.2
0.09
26
116
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
151
1257
1.22
1.52
4.9
5.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
101
807
1.27
1.48
1.1
1.1
titre
145.0
150.0
—
5
14
(3010726) Horse dander IgE Ab [Units/volume] in Serum
50
360
1.40
1.47
1.1
1.1
u/ml
0.6
2.7
2.20
20
92
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1504
14763
1.21
1.45
8.7
8.8
u/l
26.2
26.8
0.69
1470
14400
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
2088
1.17
1.43
1.9
2.7
ng/l
455.5
671.6
0.99
191
1691
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
88
1.83
1.41
1.9
1.4
%
53.8
34.8
—
10
53
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
178
0.50
1.40
1.1
1.6
—
—
—
0
0
(4268621)
9
179
0.50
1.40
1.9
2.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
68
879
0.76
1.39
3.5
4.3
ug/l
24.3
21.3
0.06
51
673
(3032080) INR in Blood by Coagulation assay
432
3943
1.13
1.38
5.2
5.9
inr
1.1
1.1
0.47
175
1291
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
231
1.48
1.37
2.2
3.4
mg/l
20.2
24.3
0.39
19
143
(1617658) Protocol used for examination of sentinel lymph nodes
5
123
0.40
1.37
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1325
12891
1.14
1.36
3.5
3.6
mmol/l
5.6
5.7
7.01
1269
12129
(40760888) Immunoglobulin light chains.free panel - Serum
8
165
0.48
1.35
2.3
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
72
558
1.30
1.35
2.6
6.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
39
0.00
1.33
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
39
0.00
1.33
0.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
119
1432
0.82
1.33
2.3
2.6
umol/l
6.4
7.0
0.17
102
1214
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
40
0.00
1.32
0.0
2.4
—
862.9
—
0
35
(40761536) Microorganisms panel - Urine sediment
141
1186
1.21
1.31
3.0
3.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
131
1094
1.21
1.31
2.5
2.2
u/l
4802.2
5766.1
0.17
58
434
(3050129) First trimester maternal screen panel - Serum or Plasma
112
922
1.23
1.29
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
280
0.60
1.27
1.8
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
833
1.24
1.27
2.9
3.2
mmol/l
1.2
1.2
0.18
87
726
(3009508) Creatinine [Moles/volume] in Urine
302
3352
0.88
1.25
2.5
3.2
mmol/l
8.0
8.1
0.07
276
2897
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
58
753
0.76
1.24
1.4
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
151
1286
1.19
1.24
2.0
2.1
nmol/l
369.8
370.1
0.01
138
1200
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
86
1.75
1.19
2.1
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
200
1751
1.16
1.19
3.6
3.3
%
20.4
21.0
0.21
71
643
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
569
5317
1.11
1.19
3.8
6.2
mmol/l
1.2
1.2
0.36
480
4510
(3000330) Specific gravity of Urine by Test strip
65
508
1.29
1.17
3.9
2.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
756
0.77
1.16
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
61
778
0.78
1.16
1.6
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
130
0.46
1.16
1.0
2.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
41
300
1.38
1.15
2.4
4.5
mmol/l
1.4
1.4
0.03
41
293
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
35
0.00
1.15
0.0
2.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
87
1.73
1.15
1.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
150
1.54
1.14
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
283
0.63
1.14
1.8
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
95
1.69
1.14
1.9
2.2
%
18.6
13.6
—
7
48
(3012516) Albumin [Mass/volume] in Urine
249
2773
0.88
1.10
2.7
3.3
mg/l
1205.8
370.2
0.80
153
1762
(1002224) Polysomnography panel
61
771
0.78
1.09
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
64
505
1.28
1.09
2.1
2.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
194
0.56
1.09
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
194
0.56
1.09
1.1
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.0
u/ml
0.0
0.0
—
5
14
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
67
534
1.27
1.06
1.5
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60
756
0.79
1.05
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
755
0.79
1.04
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
68
545
1.26
1.03
1.4
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
47
1.92
1.02
1.8
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
225
2012
1.14
1.01
2.3
2.4
ug/g
93.4
105.7
0.44
181
1608
(3013115) Eosinophils [#/volume] in Blood
729
6936
1.09
1.01
5.2
6.2
e9/l
0.2
0.2
0.32
685
6232
(3019309) Folate [Moles/volume] in Red Blood Cells
179
1576
1.15
1.01
1.5
1.6
nmol/l
1291.2
1177.2
1.11
146
1245
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
37
274
1.36
0.99
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
715
0.79
0.98
2.7
3.9
ng/l
70.7
79.0
0.59
50
648
(3003694) ABO and Rh group [Type] in Blood
473
4418
1.10
0.98
1.6
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
5
23
2.18
0.98
1.4
2.2
mmol/l
1.2
1.2
—
5
23
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
100
1.61
0.96
1.7
1.3
e6/l
5749.5
9151.6
0.29
11
70
(40768793) Breast Pathology biopsy report
24
341
0.70
0.96
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
50
635
0.78
0.96
1.4
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
32
0.00
0.95
0.0
2.2
—
2908.0
—
0
21
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
305
0.68
0.94
1.0
1.7
g/l
2.6
3.0
1.98
13
249
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
27
2.23
0.93
2.5
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
27
2.23
0.93
2.5
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
114
976
1.18
0.93
1.5
2.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
33
243
1.37
0.93
1.2
1.4
mmol/l
6.8
7.0
0.12
21
175
(3047352) Trisomy 18 risk [Likelihood] in Fetus
49
621
0.78
0.93
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
232
2564
0.89
0.92
3.4
4.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
417
0.74
0.90
2.0
2.0
iu/l
4.6
5.0
0.16
12
168
(3028300) Cannabinoids [Presence] in Urine
114
979
1.18
0.90
1.5
2.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
49
618
0.79
0.90
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
168
1.43
0.90
1.6
1.4
—
13.3
—
0
32
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
243
2204
1.12
0.89
4.3
3.6
ug/l
1.8
1.8
0.04
228
2031
(3012095) Magnesium [Moles/volume] in Serum or Plasma
153
1732
0.87
0.88
2.5
3.4
mmol/l
0.8
0.8
0.52
138
1643
(3020650) Glucose [Presence] in Urine
8
43
1.86
0.87
1.1
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
626
0.79
0.87
1.3
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
229
1.36
0.87
1.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
178
1587
1.14
0.86
1.9
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
205
1847
1.13
0.84
1.8
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
111
958
1.17
0.84
1.5
2.0
—
—
—
0
0
(4010399)
94
800
1.19
0.84
1.4
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
320
0.71
0.84
1.0
1.7
g/l
3.8
3.8
0.00
13
244
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
320
0.71
0.84
1.0
1.7
g/l
6.5
7.3
1.06
14
260
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
320
0.71
0.84
1.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
245
2233
1.11
0.83
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
50
399
1.26
0.83
2.0
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
55
444
1.25
0.83
2.1
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
112
970
1.17
0.82
1.6
2.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
29
215
1.36
0.81
1.9
2.7
mmol/l
24.7
24.8
0.06
23
198
(40768797) Stomach Pathology biopsy report
187
1683
1.13
0.79
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
24
0.00
0.79
0.0
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
108
936
1.16
0.79
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
33
1.82
0.79
1.8
2.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
25
0.00
0.79
0.0
8.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
149
0.60
0.79
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
236
2155
1.11
0.78
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
168
1504
1.13
0.78
1.3
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
52
421
1.24
0.77
1.2
1.7
g/l
0.2
0.2
0.29
45
396
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
125
0.56
0.77
1.1
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
27
0.00
0.77
0.0
8.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
27
0.00
0.77
0.0
2.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
27
0.00
0.77
0.0
1.9
—
11.9
—
0
21
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
u/ml
3.9
2.7
—
6
26
(3044007) Cell count panel - Peritoneal fluid
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
59
1.70
0.76
1.7
3.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
723
6940
1.07
0.75
5.2
5.9
e9/l
1.9
2.0
1.13
677
6263
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
149
1.41
0.75
1.5
1.4
nmol/l
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
197
0.66
0.75
1.4
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
290
2682
1.10
0.75
1.3
1.3
iu/ml
26.6
25.7
0.05
100
842
(3011412) CD3 cells [#/volume] in Blood
18
124
1.46
0.75
2.6
2.5
e9/l
1.3
1.2
0.15
13
72
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
116
1016
1.15
0.75
3.3
3.4
pmol/l
4.5
4.6
0.65
108
920
(3022145) Colonoscopy Study observation
155
1386
1.13
0.74
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
269
2911
0.91
0.74
3.6
4.0
mg/mmol
4.8
9.6
1.64
172
1848
(3002256) Pathology report gross observation
145
1623
0.88
0.73
1.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
38
1.85
0.73
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
86
999
0.85
0.73
1.8
3.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
109
0.55
0.72
2.0
3.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
109
0.55
0.72
1.3
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
110
0.54
0.72
1.2
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
76
1.58
0.71
1.1
1.1
miu/ml
2196.9
1533.9
0.88
12
76
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
168
1.37
0.71
1.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
212
1.33
0.70
1.5
1.6
mmol/l
7.3
7.4
0.11
19
128
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
143
0.63
0.69
1.3
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
62
519
1.20
0.69
2.4
3.1
g/l
139.5
131.9
2.17
62
507
(3013650) Neutrophils [#/volume] in Blood by Automated count
794
7665
1.07
0.69
7.2
8.9
e9/l
3.7
3.9
2.35
733
6783
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
157
0.63
0.69
2.2
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
58
483
1.21
0.68
1.1
1.1
u/ml
4.3
3.9
—
9
75
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
213
1.32
0.68
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
273
0.73
0.68
1.7
3.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
493
4685
1.07
0.67
3.3
3.2
u/l
29.5
30.0
0.11
468
4470
(3004588) Protein electrophoresis panel - Serum or Plasma
45
549
0.81
0.66
1.4
2.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
69
808
0.85
0.66
2.1
1.8
g/l
1.2
1.3
0.23
62
752
(3037522) Nuclear Ab [Titer] in Serum
226
2083
1.10
0.64
1.4
1.4
titre
518.3
510.1
0.02
48
408
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
398
4205
0.93
0.63
1.6
1.7
pmol/l
103.0
98.3
1.21
212
2280
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
314
3347
0.92
0.62
1.7
1.6
mmol/l
1.4
1.4
0.49
262
2916
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
21
156
1.35
0.61
1.5
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
267
0.75
0.61
6.0
5.9
iu/ml
1572.8
335.7
—
5
34
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
21
0.00
0.60
0.0
2.7
—
—
—
0
0
(4015189)
0
21
0.00
0.60
0.0
3.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
232
0.73
0.59
1.1
1.1
iu/ml
10.0
2128.8
—
6
62
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
344
0.78
0.59
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
355
0.79
0.59
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
83
725
1.15
0.59
1.8
2.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
28
219
1.28
0.58
2.1
2.7
mmol/l
2.2
2.3
0.18
21
138
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
162
0.68
0.58
2.6
2.8
u/ml
3.2
85.5
0.51
11
142
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
146
1324
1.11
0.58
1.2
1.2
iu/ml
81.0
148.7
2.48
58
529
(3045424) Erythrocytes [Presence] in Urine
29
228
1.28
0.58
1.3
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
380
3598
1.07
0.58
1.3
1.3
u/ml
1.1
1.5
0.40
147
1016
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
116
0.60
0.57
2.4
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
8
54
1.48
0.57
1.6
2.0
—
17.6
—
0
5
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
164
1790
0.91
0.56
2.1
2.6
mmol/l
2.4
2.4
0.13
156
1579
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
170
1850
0.91
0.55
1.8
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
52
440
1.19
0.55
1.2
1.7
g/l
1.2
1.2
0.28
45
414
(3015377) Calcium [Moles/volume] in Serum or Plasma
359
3788
0.93
0.55
2.2
3.2
mmol/l
2.4
2.4
0.20
338
3442
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
72
824
0.87
0.54
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
47
557
0.84
0.54
1.7
3.1
mmol/l
1.4
1.6
0.18
29
408
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
34
276
1.24
0.54
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
108
1.39
0.53
2.4
2.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
134
1.35
0.53
1.3
1.3
u/ml
0.3
0.4
0.34
12
48
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
62
1.45
0.53
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
91
1.43
0.53
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
248
2321
1.08
0.52
2.1
2.3
e6/l
6.6
7.3
0.21
219
2043
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
63
1.43
0.52
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
259
0.77
0.51
1.1
1.2
u/ml
2.3
4.8
—
6
81
(3007164) IgA [Mass/volume] in Serum or Plasma
290
3073
0.93
0.51
1.4
1.4
g/l
2.1
2.2
0.87
215
2009
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
647
6260
1.06
0.49
4.3
5.7
umol/l
9.6
10.4
2.26
616
5926
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
21
268
0.78
0.49
1.1
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1302
12842
1.07
0.48
7.9
9.0
ml/min/173m2
91.0
91.3
0.21
1105
10486
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
431
0.83
0.48
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
128
1400
0.91
0.48
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
143
0.70
0.47
1.1
1.6
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
68
1.47
0.47
1.1
1.3
u/l
141.4
440.6
—
10
60
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21
266
0.79
0.47
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
298
3144
0.94
0.47
2.8
3.7
ph
7.4
7.4
0.03
64
603
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
748
0.88
0.46
1.5
1.7
mg/l
2.6
4.4
1.01
46
511
(3035933) Granulocytes/100 leukocytes in Blood
7
49
1.43
0.46
1.3
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
37
310
1.20
0.46
1.5
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
117
0.68
0.46
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
206
2200
0.93
0.45
1.7
1.8
%
1.3
1.4
2.82
187
1992
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
374
0.83
0.45
1.3
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
690
6700
1.05
0.45
5.3
6.0
e9/l
0.0
0.0
0.45
642
5920
(3020891) Body temperature
40
338
1.19
0.45
3.2
4.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
456
4744
0.95
0.45
3.2
5.5
mmol/l
1.2
1.2
0.30
412
4360
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
160
1482
1.09
0.45
1.9
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
85
762
1.12
0.45
1.6
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
416
0.84
0.44
1.6
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
152
0.72
0.44
2.2
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
208
0.77
0.44
3.6
3.1
—
2071.5
—
0
14
(3016879) Cocaine [Presence] in Urine
99
897
1.11
0.44
1.6
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
56
489
1.15
0.43
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
346
3301
1.06
0.43
1.7
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
266
1.21
0.43
1.0
1.0
u/ml
0.0
0.4
—
7
61
(3023419) Bacteria identified in Sputum by Culture
9
128
0.70
0.43
2.3
3.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.6
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
151
0.73
0.43
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
93
0.64
0.42
1.5
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
38
323
1.18
0.41
2.3
2.3
umol/l
6.0
4.6
0.34
23
243
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
58
1.38
0.41
1.5
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
15
0.00
0.41
0.0
4.1
—
7.2
—
0
15
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
324
3393
0.94
0.41
2.3
2.7
e6/l
20.8
64.0
1.88
265
2555
(3018095) Leukocytes [#/volume] in Urine
404
4204
0.95
0.41
2.6
3.2
e6/l
51.1
69.6
0.38
286
2784
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.3
—
1.2
—
0
11
(4211845)
8
60
1.33
0.40
1.4
2.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
8.9
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
8.3
—
0.4
—
0
18
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
18
0.00
0.40
0.0
2.3
—
0.9
—
0
18
(3052592) Norovirus Ag [Presence] in Stool
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
18
0.00
0.40
0.0
9.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
102
0.68
0.39
2.7
3.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
324
0.83
0.39
1.2
1.2
u/ml
256.0
264.7
0.07
18
206
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
2046159.5
—
0
13
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
68
1.33
0.37
2.1
3.4
u/ml
894.4
749.4
—
9
68
(3047007) Chlamydophila sp Ab [Presence] in Serum
23
279
0.82
0.37
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
82
744
1.11
0.37
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
386
0.85
0.37
1.3
1.5
nmol/l
0.5
0.4
0.22
24
312
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
116
0.69
0.37
1.0
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
76
0.66
0.35
1.4
2.1
—
1.7
—
0
10
(3001604) Monocytes [#/volume] in Blood
684
6675
1.04
0.35
5.3
5.9
e9/l
0.5
0.5
1.51
642
5909
(3021901) Oxygen saturation in Capillary blood
18
144
1.25
0.35
2.0
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
169
1589
1.07
0.35
1.8
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
334
3207
1.05
0.35
1.8
2.1
u/l
153.3
182.9
0.60
312
3050
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
244
0.82
0.35
2.6
2.4
ug/min
232.0
133.2
0.17
12
160
(40767503) Oxygen content in Capillary blood by calculation
23
190
1.21
0.34
1.9
1.9
%
16.9
17.1
—
9
90
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1039
10230
1.04
0.34
2.7
2.9
u/l
40.7
40.2
0.03
1000
9796
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
73
1.37
0.34
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
181
1.22
0.34
1.1
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
189
0.79
0.34
1.5
1.5
—
—
—
0
0
(4133840)
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
45
1.33
0.33
2.3
1.4
ug/l
8.1
8.2
—
6
45
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
551
5359
1.04
0.33
2.1
2.2
nmol/l
77.0
74.3
1.61
526
5001
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
299
2867
1.05
0.33
1.9
2.0
mg/l
2.6
2.7
0.32
268
2476
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
46
1.31
0.33
1.2
3.0
—
—
—
0
0
(4024509)
6
90
0.67
0.32
1.5
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
615
6302
0.96
0.32
5.5
6.1
%
8.3
8.2
0.81
587
5976
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
83
1.33
0.32
6.0
6.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
96
1036
0.92
0.31
2.2
2.6
g/l
9.7
10.4
1.16
87
953
(40768441) Liver Pathology biopsy report
7
96
0.73
0.31
1.1
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
96
0.73
0.31
1.0
1.1
—
2.5
—
0
8
(44790048)
12
153
0.78
0.30
1.3
1.6
—
—
—
0
0
(44806118)
12
153
0.78
0.30
1.3
1.6
—
—
—
0
0
(44790047)
12
153
0.78
0.30
1.3
1.6
—
—
—
0
0
(44790049)
12
153
0.78
0.30
1.3
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
611
6255
0.96
0.30
5.2
5.9
%
2.9
2.8
0.66
583
5887
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
599
0.90
0.30
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
85
921
0.92
0.30
2.1
2.7
%
1.6
1.8
0.79
78
828
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
313
0.86
0.29
1.4
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
306
2950
1.05
0.28
1.8
2.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
44
491
0.89
0.28
1.4
1.6
—
7.1
—
0
17
(3037121) Protein [Mass/volume] in Urine
34
385
0.88
0.27
1.9
3.6
g/l
0.1
0.3
1.32
12
164
(3011288) Drugs identified in Urine by Screen method
62
677
0.91
0.27
1.7
2.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
130
1377
0.94
0.27
1.8
2.3
%
26.0
24.8
0.44
102
1190
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
120
1274
0.94
0.26
1.5
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
73
0.68
0.26
3.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
54
592
0.91
0.26
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
86
923
0.93
0.26
1.0
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
20
235
0.85
0.25
1.4
1.7
g/l
0.5
0.8
0.77
14
176
(3026782) Osmolality of Urine
224
2150
1.05
0.25
2.5
2.3
mosm/kgh2o
566.8
546.3
0.62
189
1844
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
454
1.10
0.25
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
151
1437
1.06
0.24
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
87
813
1.07
0.24
2.7
2.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
212
0.85
0.24
2.3
2.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
85
0.70
0.24
2.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
254
0.86
0.23
1.2
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
38
1.32
0.23
1.6
2.3
ug/l
44.6
51.1
—
5
38
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
33
295
1.12
0.22
1.5
1.7
—
—
—
0
0
(4094501)
36
324
1.11
0.22
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
135
0.81
0.22
1.0
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
175
1679
1.05
0.21
1.7
2.2
umol/l
15.5
14.6
0.87
157
1564
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
135
1.19
0.21
1.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.6
—
329.6
—
0
11
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
9.7
—
0
10
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
156
0.83
0.21
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
156
0.83
0.21
1.2
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
593
6038
0.97
0.21
5.2
6.0
%
0.7
0.7
0.39
565
5688
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
13.4
—
0
12
(3009343) pH of Capillary blood
53
574
0.92
0.21
1.7
3.1
ph
7.4
7.4
—
6
72
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.3
—
0
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
153
1597
0.95
0.20
1.6
2.1
s
28.1
29.4
3.36
144
1551
(3023511) Choriogonadotropin [Units/volume] in Urine
64
596
1.08
0.20
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
121
1270
0.95
0.20
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
155
0.84
0.20
1.2
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
28
313
0.89
0.20
2.0
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
111
0.81
0.20
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
176
0.85
0.20
1.5
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
18
155
1.16
0.20
3.3
1.5
mu/l
83.0
43.9
0.65
18
142
(3006462) Nitrate [Presence] in Urine
6
50
1.20
0.19
1.5
2.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
50
1.20
0.19
1.2
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
122
0.82
0.19
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
94
991
0.95
0.19
2.4
2.3
au/ml
28.3
22.2
—
10
75
(3009871) Measles virus Ab [Titer] in Serum
6
53
1.13
0.18
1.8
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
53
1.13
0.18
2.7
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
52
483
1.08
0.18
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
27
300
0.90
0.18
1.0
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
54
579
0.93
0.18
1.6
3.2
kpa
5.0
5.2
0.69
49
544
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
258
0.89
0.17
1.1
1.3
u/ml
3.0
5.2
—
7
103
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1193
11844
1.03
0.17
4.3
4.4
mmol/mol
37.6
38.2
0.69
1136
11263
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
268
0.89
0.17
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
55
587
0.93
0.16
1.7
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
246
0.89
0.16
1.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
193
0.88
0.15
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
(3036603) Volume of Urine
6
79
0.76
0.15
1.5
1.6
ml
1968.2
2217.9
—
6
12
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
83
1.21
0.15
1.5
2.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
119
0.84
0.15
1.0
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
79
1.14
0.15
1.1
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
79
1.14
0.15
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
129
1243
1.04
0.15
1.5
1.7
—
—
—
0
0
(4198724)
11
93
1.18
0.14
1.9
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
1073
0.96
0.14
1.7
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
126
1305
0.96
0.14
2.5
2.4
ug/l
0.8
0.7
0.47
59
703
(40768804) Tissue Pathology biopsy report
537
5444
0.98
0.14
1.9
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
97
1009
0.96
0.13
15.8
13.5
inr
1.2
1.2
0.16
31
170
(3045142) Bone marrow Pathology biopsy report
9
108
0.83
0.13
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
15
169
0.89
0.12
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
215
2201
0.97
0.12
1.4
1.4
nmol/l
22.0
20.8
0.65
195
1963
(3041806) Other cells [#/volume] in Blood by Manual count
12
104
1.15
0.12
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
272
0.92
0.12
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
426
0.94
0.12
1.9
2.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
30
278
1.08
0.12
1.0
1.0
u/ml
2.1
2.2
0.01
22
145
(3017732) Neutrophils [#/volume] in Blood
96
995
0.96
0.11
1.8
2.4
e9/l
3.8
4.1
1.04
89
852
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
337
1.07
0.11
1.4
1.4
ug/g
297.1
313.8
0.15
21
176
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
200
1955
1.03
0.11
2.2
3.0
ng/l
206.4
519.5
1.31
100
1178
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
178
0.90
0.11
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
157
0.89
0.11
1.1
1.4
—
—
—
0
0
(4306422)
24
260
0.92
0.11
1.2
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
18
163
1.11
0.10
1.1
1.5
—
18.3
—
0
7
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
115
1.13
0.10
1.0
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
92
889
1.04
0.10
3.0
9.7
%
96.7
96.3
0.23
86
858
(3018010) Neutrophils/100 leukocytes in Blood
643
6489
0.99
0.10
5.0
5.7
%
55.7
56.3
0.64
612
6152
(3000494) Fungus identified in Specimen by Culture
147
1507
0.97
0.10
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
156
0.90
0.10
1.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
156
0.90
0.10
1.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
257
2526
1.02
0.10
1.8
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
135
1.11
0.09
1.2
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
1051
0.97
0.09
1.7
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
47
1.06
0.09
1.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
191
1872
1.02
0.09
2.0
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
145
0.90
0.09
1.8
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
66
635
1.04
0.09
1.8
2.7
e9/l
72.9
74.7
0.13
46
463
(3011397) Hemoglobin [Presence] in Urine by Test strip
294
2897
1.02
0.09
3.7
3.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
36
341
1.06
0.08
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
401
4056
0.99
0.08
2.1
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
745
0.96
0.08
1.4
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
87
844
1.03
0.08
3.3
10.1
g/l
128.1
123.3
1.70
82
811
(3036782) Glucose [Moles/volume] in Pleural fluid
5
60
0.83
0.08
1.0
1.2
mmol/l
4.5
6.2
—
5
54
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
62
0.81
0.08
1.2
1.1
—
10.9
—
0
11
(3012565) Volume of 24 hour Urine
7
65
1.08
0.08
1.9
2.3
ml
2237.7
2022.9
—
7
60
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
164
0.91
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
358
0.95
0.08
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
133
0.90
0.07
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
98
1.12
0.07
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
76
1.05
0.07
1.3
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
357
0.95
0.07
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
98
956
1.03
0.07
1.6
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
652
6564
0.99
0.07
5.1
5.9
%
30.2
29.6
0.99
622
6211
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
84
0.83
0.07
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
206
1.07
0.07
2.0
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
214
0.93
0.07
1.9
2.0
g/l
132.3
134.2
0.13
15
159
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
94
0.85
0.06
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
103
0.87
0.06
1.2
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
105
0.86
0.06
1.2
1.2
—
51.0
—
0
5
(3038026) Centromere Ab [Units/volume] in Serum
9
105
0.86
0.06
1.2
1.2
—
92.6
—
0
7
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
266
1.05
0.06
3.2
3.7
e9/l
3.5
4.1
0.98
28
266
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
11
121
0.91
0.06
1.0
1.1
mg/l
263.5
288.9
2.04
11
112
(3015183) Erythrocyte sedimentation rate
13
119
1.09
0.06
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
253
0.95
0.05
2.3
2.1
—
—
—
0
0
(4062490)
14
151
0.93
0.05
1.4
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
212
0.94
0.05
2.1
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
104
1021
1.02
0.05
3.4
4.3
u/l
210.0
239.2
2.93
99
970
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
99
973
1.02
0.04
1.8
2.2
ml/min/173m2
81.9
77.7
0.64
45
361
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
170
0.94
0.04
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
109
0.92
0.04
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
109
0.92
0.04
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
109
0.92
0.04
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
281
0.96
0.04
1.1
1.3
—
—
—
0
0
(4027681)
13
121
1.07
0.03
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
30
311
0.96
0.03
1.2
1.4
—
22.5
—
0
5
(3026493) Urate [Moles/volume] in Serum or Plasma
308
3101
0.99
0.03
1.8
2.3
umol/l
1114.5
3399.5
1.59
289
2791
(3036489) Thrombin time
49
502
0.98
0.03
1.3
2.1
s
20.4
20.9
0.46
33
430
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
501
0.98
0.03
3.2
12.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
108
0.93
0.03
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
108
0.93
0.03
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
108
0.93
0.03
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
112
1.07
0.03
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
112
1.07
0.03
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
261
1.04
0.02
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1364
13655
0.99
0.02
9.7
11.2
%
40.1
40.5
1.10
1067
11208
(3002032) Base excess in Venous blood by calculation
80
810
0.99
0.02
2.7
3.6
mmol/l
2.1
1.9
0.32
62
657
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
25
258
0.97
0.02
3.6
2.7
nmol/l
0.7
0.9
1.13
20
220
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
93
1.08
0.02
1.5
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
272
1.03
0.02
3.6
4.0
%
55.6
56.5
0.17
28
272
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
113
1.06
0.02
1.5
1.5
umol/l
9.4
10.4
0.41
12
106
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
153
1.05
0.01
1.6
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
475
4739
1.00
0.01
4.0
4.6
g/l
37.2
36.9
0.63
446
4439
(3004789) Transferrin [Mass/volume] in Serum or Plasma
154
1531
1.01
0.01
1.7
2.2
g/l
2.6
2.4
2.41
138
1430
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
263
1.03
0.01
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
91
918
0.99
0.01
1.3
1.3
au/ml
40.5
33.5
—
5
43
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
33
323
1.02
0.01
1.1
1.2
mmol/l
3.7
3.7
0.01
33
303
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
45
443
1.02
0.01
1.3
2.1
%
91.3
93.8
0.38
40
408
(3027801) Oxygen [Partial pressure] in Arterial blood
102
1027
0.99
0.01
3.0
8.9
kpa
13.6
13.1
0.42
97
979
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
102
1027
0.99
0.01
3.0
8.9
kpa
4.9
5.1
2.35
97
976
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
19
184
1.03
0.00
1.1
1.1
g/l
1.4
1.4
0.17
19
167
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
196
0.97
0.00
1.2
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
286
0.98
0.00
1.3
1.4
u/ml
122.1
105.3
—
8
56
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
464
1.01
0.00
1.5
2.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
114
0.96
0.00
1.0
1.1
u/l
1.0
1.0
—
6
57
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
136
1.03
0.00
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
41
406
1.01
0.00
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
41
406
1.01
0.00
1.1
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
11
112
0.98
0.00
4.2
3.7
u/ml
22.8
55.4
1.05
11
112
(3003396) Base excess in Arterial blood by calculation
102
1016
1.00
0.00
3.0
9.0
mmol/l
1.3
1.1
0.25
64
788
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
292
0.99
0.00
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
179
1.01
0.00
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
179
1.01
0.00
1.9
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
181
0.99
0.00
1.7
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
411
1.00
0.00
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
103
0.97
0.00
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
197
1.02
0.00
1.9
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
203
0.99
0.00
1.6
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
307
1.01
0.00
1.2
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
145
0.97
0.00
1.3
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
115
0.96
0.00
1.5
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.9
—
4.2
—
0
9
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
180.7
—
0
9
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
55
0.91
0.00
1.0
1.5
pmol/l
13.8
13.5
—
5
49
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
2.8
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
130
1.00
0.00
1.5
1.5
g/l
1.0
1.0
0.02
13
130
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
98
0.92
0.00
1.3
2.0
pg
32.8
32.4
—
9
98
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
98
0.92
0.00
1.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
91
0.99
0.00
1.1
1.2
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.1
—
389.0
—
0
7
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
76
0.92
0.00
2.6
2.3
ug/l
17.6
125.0
—
7
66
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
2.8
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
20.1
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
69
0.87
0.00
1.5
1.5
nmol/l
124.3
137.9
—
6
69
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
69
0.87
0.00
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
98
0.92
0.00
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
52
0.96
0.00
1.6
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
86
0.93
0.00
1.0
1.4
%
—
64.2
—
0
10
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
921.8
—
0
5
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
33.5
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
68
0.88
0.00
1.0
1.1
iu/ml
126.2
178.5
—
6
68
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
1.6
—
2.3
—
0
8
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
8.3
—
0
5
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: OPER_LEFORT1_BSSRO – LeFortI or BSSRO operation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).